 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- Lendormin (brotizolam) / Boehringer Ingelheim
Enrollment change, Trial primary completion date: Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults (clinicaltrials.gov) - Jan 30, 2015
P1/2, N=10, Completed, Sponsor: Coeruleus Ltd.
N=20 --> 10 | Trial primary completion date: Sep 2010 --> Aug 2012
- flumazenil sublingual / Generic mfg.
Trial completion, Trial initiation date, Trial primary completion date: Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults (clinicaltrials.gov) - Jan 30, 2015
P1, N=10, Completed, Sponsor: Coeruleus Ltd.
N=20 --> 10 | Trial primary completion date: Sep 2010 --> Aug 2012 Recruiting --> Completed | Initiation date: Jul 2012 --> Jul 2010 | Trial primary completion date: Dec 2012 --> Dec 2010
- flumazenil sublingual / Generic mfg.
Trial termination: A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder (clinicaltrials.gov) - Apr 17, 2014
P2a, N=11, Terminated, Sponsor: Parkway Medical Center
Recruiting --> Completed | Initiation date: Jul 2012 --> Jul 2010 | Trial primary completion date: Dec 2012 --> Dec 2010 Recruiting --> Terminated; Study completed and data was inconclusive.
- flumazenil sublingual / Generic mfg.
Enrollment change: A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder (clinicaltrials.gov) - Apr 17, 2014
P2a, N=11, Terminated, Sponsor: Parkway Medical Center
Recruiting --> Terminated; Study completed and data was inconclusive. N=40 --> 11
- flumazenil sublingual / Generic mfg.
New P1 trial: Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults (clinicaltrials.gov) - Jul 31, 2012
P1, N=10, Recruiting, Sponsor: Coeruleus Ltd.
- flumazenil sublingual / Generic mfg.
Trial completion: Flumazenil for the Treatment of Primary Hypersomnia (clinicaltrials.gov) - Mar 15, 2012
P1/2, N=10, Completed, Sponsor: Lynn Marie Trotti
N=40 --> 11 Recruiting --> Completed